These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2978804)

  • 21. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction.
    Emdin M; Passino C; Michelassi C; Titta F; L'abbate A; Donato L; Pompella A; Paolicchi A
    Eur Heart J; 2001 Oct; 22(19):1802-7. PubMed ID: 11549302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lipoprotein (a)].
    del Río A
    Med Clin (Barc); 1991 Oct; 97(12):453-5. PubMed ID: 1836519
    [No Abstract]   [Full Text] [Related]  

  • 23. [Relation of serum apolipoprotein and lipoprotein and coronary atherosclerosis].
    Morimoto S; Hiasa Y; Maeda T; Harada M; Wada T; Aihara T; Bando M; Nakai Y; Kataoka Y; Mori H
    Kokyu To Junkan; 1986 Nov; 34(11):1221-6. PubMed ID: 3809751
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q.
    Shah SH; Kraus WE; Crossman DC; Granger CB; Haines JL; Jones CJ; Mooser V; Huang L; Haynes C; Dowdy E; Vega GL; Grundy SM; Vance JM; Hauser ER
    Ann Hum Genet; 2006 Nov; 70(Pt 6):738-48. PubMed ID: 17044848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein(a) concentrations are increased in patients with myocardial infarction and angiographically normal coronary arteries.
    Graziani MS; Zanolla L; Righetti G; Nicoli M; Modena N; Dimitri G; Menegatti G; Vassanelli C
    Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):135-7. PubMed ID: 8490059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Blood lipids and myocardial infarct. Correlation between lipoprotein patterns and coronary heart disease confirmed].
    Schwandt P
    MMW Munch Med Wochenschr; 1984 Feb; 126(8):185-6. PubMed ID: 6425656
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the coronary risk: is it enough to asses ApoB/ApoA1 ratio only or is plasma lipoprotein concentration still necessary?].
    Cybulska B
    Kardiol Pol; 2005 Feb; 62(2):153-6. PubMed ID: 15815801
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoprotein(a) levels in patients with unstable angina and their relationship with atherothrombosis and myocardial damage.
    Yazici M; Demircan S; Durna K; Sahin M
    Int J Clin Pract; 2005 Feb; 59(2):150-5. PubMed ID: 15854189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum remnant lipoprotein levels in nephrotic syndrome.
    Kinoshita H; Uezono S; Fukudome K; Yokota N; Hisanaga S; Fujimoto S; Eto T
    Clin Nephrol; 2001 Mar; 55(3):263-4. PubMed ID: 11316252
    [No Abstract]   [Full Text] [Related]  

  • 30. Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction.
    Lekhal S; Børvik T; Nordøy A; Hansen JB
    Nutr Metab Cardiovasc Dis; 2008 Dec; 18(10):700-6. PubMed ID: 18194851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design features of a five-year Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
    de Faire U; Ericsson CG; Hamsten A; Nilsson J
    Drugs Exp Clin Res; 1995; 21(3):105-24. PubMed ID: 7555614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein (a) in relation to atherosclerotic diseases.
    Dahlén GH
    Prog Clin Biol Res; 1988; 255():27-36. PubMed ID: 2448830
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipoprotein(a) may have contrasting effects on different aspects of atherosclerotic coronary disease.
    Narang R; Niththyananthan S; Nonis C; Thompson GR; Davies G
    Circulation; 1995 Oct; 92(8):2354-5. PubMed ID: 7554223
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a)--II.
    De Bono D
    J Am Coll Cardiol; 1997 Mar; 29(4):887-8; author reply 888-9. PubMed ID: 9091538
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a)--I.
    Enas EA
    J Am Coll Cardiol; 1997 Mar; 29(4):887; author reply 888-9. PubMed ID: 9091537
    [No Abstract]   [Full Text] [Related]  

  • 36. The complexity of ABO in coronary heart disease.
    Carpeggiani C
    Lancet; 2011 Apr; 377(9776):1492-3; author reply 1493-4. PubMed ID: 21531265
    [No Abstract]   [Full Text] [Related]  

  • 37. New lipoprotein profiles and coronary heart disease. Improving precision of risk.
    Nestel PJ
    Circulation; 1990 Aug; 82(2):649-51. PubMed ID: 2372911
    [No Abstract]   [Full Text] [Related]  

  • 38. Is lipoprotein(a) an independent risk factor for myocardial infarction at a young age?
    Hutchesson AC
    Clin Chem; 1990 Jun; 36(6):1258. PubMed ID: 2141556
    [No Abstract]   [Full Text] [Related]  

  • 39. The complexity of ABO in coronary heart disease.
    Dahabreh IJ; Kitsios GD; Trikalinos TA; Kent DM
    Lancet; 2011 Apr; 377(9776):1493; author reply 1493-4. PubMed ID: 21531266
    [No Abstract]   [Full Text] [Related]  

  • 40. Whole-Blood Transcriptome Profiling Identifies Women With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Barrett TJ; Lee AH; Smilowitz NR; Hausvater A; Fishman GI; Hochman JS; Reynolds HR; Berger JS
    Circ Genom Precis Med; 2018 Dec; 11(12):e002387. PubMed ID: 30562118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.